sameAs
P527
Analysis of Soluble Mediators, Cytokines, and Circulating Angiogenic Factors (FACs) as Potential Predictors / Prognostic Factors in Advanced Non-squamous Lung CarcinomaLidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy PracticeHome Telehealth Follow-up After Hospital Discharge for Chronic Obstructive Pulmonary Disease (COPD) PatientsImpact of M-health Based Intervention on Adherence to Healthy Physical Activity After Stroke.An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian CancerPETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 YearsEffectiveness of Analgesia in Total Knee ArthroplastyLidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography PracticeLong-Term Follow-up StudyPALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
P6153
Q47449113-100D208B-E18C-4DA5-A23C-F9595BA6147AQ47449113-E56B47D1-0905-4DD6-B674-ADF66AC5A889Q49672184-E5F206C1-833D-4143-B18F-61F1255F0BADQ51925472-EA234070-C87B-4FCF-AE1F-2F59D5DE9082Q51925472-EDE48F5B-3D57-43D0-8149-C36DDF65DC5EQ64539410-0AE9B59F-382D-416F-8B32-0CAD64AFD98AQ73744387-41F1C0BA-2FA1-4FF3-BDCC-4070E63F827BQ73744387-919E2D49-D16A-40E7-9763-525B1351379DQ73744387-FD34D562-D723-48E3-8347-4CDB76D78C92Q81599211-B33E8360-3783-494B-807C-C33E538C77C7Q84421244-2EC39868-D01F-457F-933F-5C0CD0F7D3F8Q84885940-D350EF3F-5AEC-44B2-8506-E679AF50AA63Q86081409-D2014396-2701-4F41-B6FF-37DBCC255186Q86374128-49FEA624-C336-40B2-A4DA-099815B1BB20Q87778651-190EB947-AB18-4BF0-B823-284191E614B4Q88536455-0B6C624B-2AF9-47D6-9AFC-825AAC6D455AQ89098641-EB0650EC-95CE-4A15-BB12-7DA75AFD39F1
P108
Q61909550-7A47FFA4-3F27-462E-9E4A-1A9B29AA6184Q61936827-9BF081C6-B0AC-4D76-A882-4D5EF2524480Q61955738-EB86E61C-5C03-430E-96E3-EDD2C5DDD392Q62822282-CBB4E4FC-E047-4AA2-8C3D-A6238D74B8FBQ63063041-8BEA7B4B-3EF1-4CC6-938B-0C13949258B5Q63336106-86C28CF5-5F7C-4984-8F54-03C68E480F2DQ63336814-A8610E61-1626-4191-BF62-596743BE13F9Q63337028-731D32CD-859F-4305-A624-3B11FFB4225CQ63405135-08C0F2AC-438C-4F3D-A0EF-56E091BE997DQ64139342-E8E1D582-F8C4-46F2-905B-178CCD4FEB70
P6153
description
Organisation
@de
organisaatio
@fi
organization
@en
organizatë
@sq
name
Consorci Sanitari de Terrassa
@ca
Consorci Sanitari de Terrassa
@de
Consorci Sanitari de Terrassa
@en
Consorci Sanitari de Terrassa
@es
Consorci Sanitari de Terrassa
@eu
Consorci Sanitari de Terrassa
@fr
Consorci Sanitari de Terrassa
@it
Consorci Sanitari de Terrassa
@nl
Consorci Sanitari de Terrassa
@pt
type
label
Consorci Sanitari de Terrassa
@ca
Consorci Sanitari de Terrassa
@de
Consorci Sanitari de Terrassa
@en
Consorci Sanitari de Terrassa
@es
Consorci Sanitari de Terrassa
@eu
Consorci Sanitari de Terrassa
@fr
Consorci Sanitari de Terrassa
@it
Consorci Sanitari de Terrassa
@nl
Consorci Sanitari de Terrassa
@pt
altLabel
CST
@en
prefLabel
Consorci Sanitari de Terrassa
@ca
Consorci Sanitari de Terrassa
@de
Consorci Sanitari de Terrassa
@en
Consorci Sanitari de Terrassa
@es
Consorci Sanitari de Terrassa
@eu
Consorci Sanitari de Terrassa
@fr
Consorci Sanitari de Terrassa
@it
Consorci Sanitari de Terrassa
@nl
Consorci Sanitari de Terrassa
@pt
P214
P131
P17
P213
0000 0000 9840 9189
P214
P2427
grid.476208.f
P3500
P452
P571
1989-01-01T00:00:00Z
P625
Point (2.053542 41.556347)
P6782
P7859
viaf-145813341